Cav-1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Gai-Li Jia1, Qi Huang1, Yan-Nan Cao1
1Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Pain Medicine Institute of Wenzhou Medical University, Zhejiang, China.
Abstract:
This study aims to determine whether caveolin-1 (Cav-1) participates in the process of diabetic neuropathic pain by directly regulating the expression of toll-like receptor 4 (TLR4) and the subsequent phosphorylation of N-methyl-D-aspartate receptor 2B subunit (NR2B) in the spinal cord. Male Sprague-Dawley rats (120-150 g) were continuously fed with high-fat and high-sugar diet for 8 weeks, and received a single low-dose of intraperitoneal streptozocin injection in preparation for the type-II diabetes model. Then, these rats were divided into five groups according to the level of blood glucose, and the mechanical withdrawal threshold and thermal withdrawal latency values. The pain thresholds were measured at 3, 7, and 14 days after animal grouping. Then, eight rats were randomly chosen from each group and killed. Lumbar segments 4-6 of the spinal cord were removed for western blot analysis and immunofluorescence assay. Cav-1 was persistently upregulated in the spinal cord after diabetic neuropathic pain in rats. The downregulation of Cav-1 through the subcutaneous injection of Cav-1 inhibitor daidzein ameliorated the pain hypersensitivity and TLR4 expression in the spinal cord in diabetic neuropathic pain (DNP) rats. Furthermore, it was found that Cav-1 directly bound with TLR4, and the subsequent phosphorylation of NR2B in the spinal cord contributed to the modulation of DNP. These findings suggest that Cav-1 plays a vital role in DNP processing at least in part by directly regulating the expression of TLR4, and through the subsequent phosphorylation of NR2B in the spinal cord.
Insights
Caveolin-1 (Cav-1) regulates toll-like receptor 4 (TLR4) and N-methyl-D-aspartate receptor 2B subunit (NR2B) phosphorylation, impacting diabetic neuropathic pain (DNP). Inhibiting Cav-1 reduced pain and TLR4 expression in DNP rats.
Area of Science:
- Neuroscience
- Endocrinology
- Pain Research
Background:
- Diabetic neuropathic pain (DNP) is a debilitating complication of diabetes.
- The molecular mechanisms underlying DNP are not fully understood.
- Caveolin-1 (Cav-1) is implicated in various cellular processes, but its role in DNP requires elucidation.
Purpose of the Study:
- To investigate the role of caveolin-1 (Cav-1) in the development of diabetic neuropathic pain (DNP).
- To determine if Cav-1 directly regulates toll-like receptor 4 (TLR4) expression and N-methyl-D-aspartate receptor 2B subunit (NR2B) phosphorylation in the spinal cord.
- To explore Cav-1 as a potential therapeutic target for DNP.
Main Methods:
- A type-II diabetes model was established in Sprague-Dawley rats using a high-fat/high-sugar diet and streptozocin injection.
- Mechanical withdrawal threshold and thermal withdrawal latency were measured to assess pain sensitivity.
- Western blot and immunofluorescence assays were performed on spinal cord tissues.
- Cav-1 expression and its interaction with TLR4 and NR2B phosphorylation were analyzed.
- The effect of a Cav-1 inhibitor (daidzein) on pain and molecular markers was evaluated.
Main Results:
- Cav-1 expression was persistently upregulated in the spinal cord of DNP rats.
- Downregulation of Cav-1 using daidzein significantly ameliorated pain hypersensitivity and reduced TLR4 expression.
- Cav-1 was found to directly bind with TLR4.
- The phosphorylation of NR2B in the spinal cord was modulated by Cav-1 and TLR4 interaction, contributing to DNP.
Conclusions:
- Caveolin-1 (Cav-1) plays a significant role in the processing of diabetic neuropathic pain (DNP).
- Cav-1 directly regulates toll-like receptor 4 (TLR4) expression, which in turn influences N-methyl-D-aspartate receptor 2B subunit (NR2B) phosphorylation in the spinal cord.
- Targeting Cav-1 may offer a novel therapeutic strategy for managing DNP.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway

